{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,6]],"date-time":"2026-01-06T02:20:36Z","timestamp":1767666036477},"reference-count":38,"publisher":"Hindawi Limited","issue":"2","license":[{"start":{"date-parts":[[2015,9,1]],"date-time":"2015-09-01T00:00:00Z","timestamp":1441065600000},"content-version":"tdm","delay-in-days":963,"URL":"http:\/\/doi.wiley.com\/10.1002\/tdm_license_1.1"}],"content-domain":{"domain":["wiley.com"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2013,2]]},"DOI":"10.1111\/ijcp.12078","type":"journal-article","created":{"date-parts":[[2013,1,11]],"date-time":"2013-01-11T10:14:04Z","timestamp":1357899244000},"page":"128-138","update-policy":"http:\/\/dx.doi.org\/10.1002\/crossmark_policy","source":"Crossref","is-referenced-by-count":3,"title":["The A<sub>1<\/sub>chieve study - an observational non-interventional study of patients with type 2 diabetes mellitus initiating or switched to insulin analogue therapy: subgroup analysis of the Gulf population"],"prefix":"10.1155","volume":"67","author":[{"given":"N.","family":"El-Naggar","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"A.","family":"Almansari","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"K.","family":"Khudada","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"S.","family":"Salman","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"N.","family":"Mariswamy","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"W.","family":"AbdelFattah","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"F.","family":"Hashim","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"98","published-online":{"date-parts":[[2013,1,11]]},"reference":[{"key":"10.1111\/ijcp.12078-BIB1|cit1","unstructured":"World Health Organization Fact sheet Nu312 Diabetes http:\/\/www.who.int\/mediacentre\/factsheets\/fs312\/en\/"},{"key":"10.1111\/ijcp.12078-BIB2|cit2","doi-asserted-by":"crossref","first-page":"609","DOI":"10.1016\/S0025-6196(11)62412-9","article-title":"Glycaemic control, mealtime glucose excursions, and diabetic complications in type 2 diabetes mellitus","volume":"76","author":"Palumbo","year":"2001","journal-title":"Mayo Clin Proc"},{"key":"10.1111\/ijcp.12078-BIB3|cit3","first-page":"332","article-title":"Prevention of long-term complications of non-insulin dependent diabetes mellitus","volume":"18","author":"Nathan","year":"1995","journal-title":"Clin Invest Med"},{"key":"10.1111\/ijcp.12078-BIB4|cit4","doi-asserted-by":"crossref","first-page":"243","DOI":"10.1016\/S0889-8529(05)70323-6","article-title":"Diabetic complications: the importance of glucose control","volume":"25","author":"Skyler","year":"1996","journal-title":"Endocrinol Metab Clin North Am"},{"key":"10.1111\/ijcp.12078-BIB5|cit5","doi-asserted-by":"crossref","first-page":"90","DOI":"10.7326\/0003-4819-124-1_Part_2-199601011-00003","article-title":"Relation of glycaemic control to diabetic microvascular complications in diabetes mellitus","volume":"124","author":"Klein","year":"1996","journal-title":"Ann Intern Med"},{"key":"10.1111\/ijcp.12078-BIB6|cit6","doi-asserted-by":"crossref","first-page":"311","DOI":"10.1016\/j.diabres.2011.10.029","article-title":"IDF diabetes atlas: global estimates of the prevalence of diabetes for 2011 and 2030","volume":"94","author":"Whiting","year":"2011","journal-title":"Diabetes Res Clin Pract"},{"key":"10.1111\/ijcp.12078-BIB7|cit7","volume-title":"IDF Diabetes Atlas","author":"International Diabetes Federation","year":"2011"},{"key":"10.1111\/ijcp.12078-BIB8|cit8","unstructured":"Khoja T. Strategic approaches in combating diabetes mellitus among GCC countries, first BA Regional Workshop on the Epidemiology of Diabetes and Other Non-Communicable Diseases 2009 http:\/\/www.pitt.edu\/~super1\/lecture\/lec33631\/001.htm"},{"key":"10.1111\/ijcp.12078-BIB9|cit9","unstructured":"International Diabetes Federation Diabetes Atlas 3 2006"},{"key":"10.1111\/ijcp.12078-BIB10|cit10","doi-asserted-by":"crossref","first-page":"1249","DOI":"10.2337\/diab.44.11.1249","article-title":"Overview of 6\u2003years\u2019 therapy of type II diabetes: a progressive disease","volume":"44","author":"U.K. Prospective Diabetes Study Group","year":"1995","journal-title":"Diabetes"},{"key":"10.1111\/ijcp.12078-BIB11|cit11","doi-asserted-by":"crossref","first-page":"2005","DOI":"10.1001\/jama.281.21.2005","article-title":"Glycaemic control with diet, sulfonylurea, metformin, or insulin in patients with type 2 diabetes mellitus: progressive requirement for multiple therapies (UKPDS 49)","volume":"281","author":"Turner","year":"1999","journal-title":"JAMA"},{"key":"10.1111\/ijcp.12078-BIB12|cit12","doi-asserted-by":"crossref","first-page":"3080","DOI":"10.2337\/diacare.26.11.3080","article-title":"Insulin Glargine 4002 Study Investigators. The treat-to-target trial: randomized addition of glargine or human NPH insulin to oral therapy of type 2 diabetic patients","volume":"26","author":"Riddle","year":"2003","journal-title":"Diabetes Care"},{"key":"10.1111\/ijcp.12078-BIB13|cit13","doi-asserted-by":"crossref","first-page":"1289","DOI":"10.2337\/diab.45.10.1289","article-title":"The absence of a glycaemic threshold for the development of long-term complications: the perspective of the Diabetes Control and Complications Trial","volume":"45","author":"Diabetes Control and Complications Trial (DCCT) research Group","year":"1996","journal-title":"Diabetes"},{"key":"10.1111\/ijcp.12078-BIB14|cit14","doi-asserted-by":"crossref","first-page":"837","DOI":"10.1016\/S0140-6736(98)07019-6","article-title":"Intensive blood glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33)","volume":"352","author":"UK Prospective Diabetes Study (UKPDS) Group","year":"1998","journal-title":"Lancet"},{"issue":"Suppl. 1","key":"10.1111\/ijcp.12078-BIB15|cit15","doi-asserted-by":"crossref","first-page":"S28","DOI":"10.2337\/diacare.26.2007.S28","article-title":"Implications of the United Kingdom Prospective Diabetes Study","volume":"26","author":"American Diabetes Association","year":"2003","journal-title":"Diabetes Care"},{"issue":"Suppl. 1","key":"10.1111\/ijcp.12078-BIB16|cit16","doi-asserted-by":"crossref","first-page":"S11","DOI":"10.2337\/dc11-S011","article-title":"Standards of medical care in diabetes-2011","volume":"34","author":"American Diabetes Association","year":"2011","journal-title":"Diabetes Care"},{"issue":"Suppl. 1","key":"10.1111\/ijcp.12078-BIB17|cit17","first-page":"40","article-title":"Medical guidelines for the management of diabetes mellitus: the AACE system of intensive diabetes self-management-2002 update","volume":"8","author":"American Association of Clinical Endocrinologists","year":"2002","journal-title":"Endocr Pract"},{"key":"10.1111\/ijcp.12078-BIB18|cit18","doi-asserted-by":"crossref","first-page":"352","DOI":"10.1016\/j.diabres.2011.10.021","article-title":"An observational non-interventional study of people with diabetes beginning or changed to insulin analogue therapy in non-Western countries: The A1chieve study","volume":"94","author":"Home","year":"2011","journal-title":"Diabetes Res Clin Pract"},{"key":"10.1111\/ijcp.12078-BIB19|cit19","doi-asserted-by":"crossref","first-page":"522","DOI":"10.1111\/j.1742-1241.2009.02002.x","article-title":"Initiating insulin therapy with, or switching existing insulin therapy to, biphasic insulin aspart 30\/70 (NovoMix\u00ae30) in routine care: safety and effectiveness in patients with type 2 diabetes in the IMPROVE observational study","volume":"63","author":"Valensi","year":"2009","journal-title":"Int J Clin Pract"},{"issue":"1 Suppl.","key":"10.1111\/ijcp.12078-BIB20|cit20","doi-asserted-by":"crossref","first-page":"9S","DOI":"10.1177\/0145721705285638","article-title":"Dispelling myths and removing barriers about insulin in type 2 diabetes","volume":"32","author":"Meece","year":"2006","journal-title":"Diabetes Educ"},{"key":"10.1111\/ijcp.12078-BIB21|cit21","first-page":"2","article-title":"Initiating Insulin Therapy in Patients with Type 2 Diabetes: A Practical Approach","volume":"6","author":"Cooppan","year":"2007","journal-title":"The Internet Journal of Internal Medicine"},{"key":"10.1111\/ijcp.12078-BIB22|cit22","first-page":"S13","article-title":"Safety and effectiveness of modern insulin therapy: the value of insulin analogues","volume":"49","author":"Brunton","year":"2009","journal-title":"Consultant"},{"key":"10.1111\/ijcp.12078-BIB23|cit23","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1111\/j.1463-1326.2008.00915.x","article-title":"Comparison of insulin analog regimens in patients with type 2 diabetes mellitus in the PREFER Study: a randomized controlled trial","volume":"11","author":"Liebl","year":"2009","journal-title":"Diabetes Obes Metab"},{"key":"10.1111\/ijcp.12078-BIB24|cit24","doi-asserted-by":"crossref","first-page":"727","DOI":"10.4158\/EP10367.OR","article-title":"A comparison of two intensification regimens with rapid-acting insulin aspart in type 2 diabetes inadequately controlled by once-daily insulin detemir and oral antidiabetes drugs: the STEP-WiseTM randomized study","volume":"17","author":"Meneghini","year":"2011","journal-title":"Endocr Pract"},{"key":"10.1111\/ijcp.12078-BIB25|cit25","doi-asserted-by":"crossref","first-page":"645","DOI":"10.1185\/030079908X260952","article-title":"Biphasic insulin aspart 30 treatment in patients with type 2 diabetes poorly controlled on prior diabetes treatment: results from the PRESENT study","volume":"24","author":"Sharma","year":"2008","journal-title":"Curr Med Res Opin"},{"key":"10.1111\/ijcp.12078-BIB26|cit26","doi-asserted-by":"crossref","first-page":"330","DOI":"10.2337\/diacare.25.2.330","article-title":"For the UK Prospective Diabetes Study Group. Sulfonylurea inadequacy: efficacy of addition of insulin over 6\u2003years in patients with type 2 diabetes in the UK Prospective Diabetes Study (UKPDS 57)","volume":"25","author":"Wright","year":"2002","journal-title":"Diabetes Care"},{"issue":"Suppl. 2","key":"10.1111\/ijcp.12078-BIB27|cit27","doi-asserted-by":"crossref","first-page":"S14","DOI":"10.1038\/sj.ijo.0802745","article-title":"The reality of glycaemic control in insulin treated diabetes: defining the clinical challenges","volume":"28","author":"Davies","year":"2004","journal-title":"Int J Obes Relat Metab Disord"},{"key":"10.1111\/ijcp.12078-BIB28|cit28","doi-asserted-by":"crossref","first-page":"428","DOI":"10.1111\/j.1463-1326.2006.00677.x","article-title":"PREDICTIVE - a global, prospective observational study to evaluate insulin detemir treatment in types 1 and 2 diabetes: baseline characteristics and predictors of hypoglycaemia from the European cohort","volume":"9","author":"Luddeke","year":"2007","journal-title":"Diabetes Obes Metab"},{"key":"10.1111\/ijcp.12078-BIB29|cit29","doi-asserted-by":"crossref","first-page":"1809","DOI":"10.1111\/j.1742-1241.2008.01917.x","article-title":"The IMPROVE study - a multinational, observational study in type 2 diabetes: baseline characteristics from eight national cohorts","volume":"62","author":"Valensi","year":"2008","journal-title":"Int J Clin Pract"},{"key":"10.1111\/ijcp.12078-BIB30|cit30","doi-asserted-by":"crossref","first-page":"2673","DOI":"10.2337\/diacare.28.11.2673","article-title":"International DAWN Advisory Panel. Resistance to insulin therapy among patients and providers: results of the cross-national Diabetes Attitudes, Wishes, and Needs (DAWN) study","volume":"28","author":"Peyrot","year":"2005","journal-title":"Diabetes Care"},{"issue":"Suppl. 3","key":"10.1111\/ijcp.12078-BIB31|cit31","doi-asserted-by":"crossref","first-page":"S18","DOI":"10.1038\/sj.ijo.0802173","article-title":"When oral agents fail: practical barriers to starting insulin","volume":"26","author":"Korytkowski","year":"2002","journal-title":"Int J Obes Relat Metab Disord"},{"issue":"Suppl. 1","key":"10.1111\/ijcp.12078-BIB32|cit32","doi-asserted-by":"crossref","first-page":"S11","DOI":"10.1016\/S0168-8227(10)70003-6","article-title":"The A1chieve study: a 60,000-patient, global, prospective, observational study of basal, meal-time, and biphasic insulin analogues in daily clinical practice","volume":"88","author":"Shah","year":"2010","journal-title":"Diabetes Res Clin Pract"},{"key":"10.1111\/ijcp.12078-BIB33|cit33","doi-asserted-by":"crossref","first-page":"966","DOI":"10.1111\/j.1742-1241.2009.02064.x","article-title":"Intensification to biphasic insulin aspart 30\/70 (BIAsp 30, NovoMix\u00ae30) can improve glycaemic control in patients treated with basal insulins: a subgroup analysis of the IMPROVE observational study","volume":"63","author":"Gumprecht","year":"2009","journal-title":"Int J Clin Pract"},{"key":"10.1111\/ijcp.12078-BIB34|cit34","first-page":"275","article-title":"Improved glycaemic control with no weight gain: a 26-week, open label, non-randomised, non-interventional observational study on type 2 diabetes subjects using insulin detemir","volume":"109","author":"Tripathi","year":"2011","journal-title":"J Indian Med Assoc"},{"key":"10.1111\/ijcp.12078-BIB35|cit35","first-page":"1960","article-title":"Postprandial glycemic control using insulin aspart with NPH in inadequately controlled diabetics","volume":"89","author":"Gao","year":"2009","journal-title":"Zhonghua Yi Xue Za Zhi"},{"key":"10.1111\/ijcp.12078-BIB36|cit36","doi-asserted-by":"crossref","first-page":"2137","DOI":"10.2337\/dc06-1120","article-title":"Lower baseline glycemia reduces apparent oral agent glucose-lowering efficacy: a meta-regression analysis","volume":"29","author":"Bloomgarden","year":"2006","journal-title":"Diabetes Care"},{"key":"10.1111\/ijcp.12078-BIB37|cit37","doi-asserted-by":"crossref","first-page":"1016","DOI":"10.1046\/j.1464-5491.2003.01072.x","article-title":"Hypoglycaemia in insulin-treated Type 2 diabetes: frequency, symptoms and impaired awareness","volume":"20","author":"Henderson","year":"2003","journal-title":"Diabet Med"},{"key":"10.1111\/ijcp.12078-BIB38|cit38","doi-asserted-by":"crossref","first-page":"268","DOI":"10.1111\/j.1463-1326.2010.01351.x","article-title":"Efficacy and safety of insulin detemir once daily in combination with sitagliptin and metformin: the TRANSITION randomized controlled trial","volume":"13","author":"Hollander","year":"2011","journal-title":"Diabetes Obes Metab"}],"container-title":["International Journal of Clinical Practice"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1111%2Fijcp.12078","content-type":"unspecified","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2022,2,5]],"date-time":"2022-02-05T19:22:13Z","timestamp":1644088933000},"score":1,"resource":{"primary":{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/10.1111\/ijcp.12078"}},"subtitle":["A<sub>1<\/sub>chieve study: Gulf subgroup analysis"],"short-title":[],"issued":{"date-parts":[[2013,1,11]]},"references-count":38,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2013,2]]}},"URL":"https:\/\/doi.org\/10.1111\/ijcp.12078","relation":{},"ISSN":["1368-5031"],"issn-type":[{"value":"1368-5031","type":"print"}],"subject":[],"published":{"date-parts":[[2013,1,11]]},"assertion":[{"value":"2013-01-11","name":"published_online","label":"Published Online","group":{"name":"publication_history","label":"Publication History"}}]}}